CL2008000355A1 - Procedimiento de preparacion de un compuesto derivado de 1-metil-2-fenilamino metil-1h-benzoimidazol-5-amida; compuesto intermediario hidrobromuro. - Google Patents

Procedimiento de preparacion de un compuesto derivado de 1-metil-2-fenilamino metil-1h-benzoimidazol-5-amida; compuesto intermediario hidrobromuro.

Info

Publication number
CL2008000355A1
CL2008000355A1 CL200800355A CL2008000355A CL2008000355A1 CL 2008000355 A1 CL2008000355 A1 CL 2008000355A1 CL 200800355 A CL200800355 A CL 200800355A CL 2008000355 A CL2008000355 A CL 2008000355A CL 2008000355 A1 CL2008000355 A1 CL 2008000355A1
Authority
CL
Chile
Prior art keywords
compound
metil
amida
benzoimidazol
phenylamine
Prior art date
Application number
CL200800355A
Other languages
English (en)
Inventor
Wolfgang Sobotta Raine Broeder
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CL2008000355A1 publication Critical patent/CL2008000355A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CL200800355A 2007-02-06 2008-02-05 Procedimiento de preparacion de un compuesto derivado de 1-metil-2-fenilamino metil-1h-benzoimidazol-5-amida; compuesto intermediario hidrobromuro. CL2008000355A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07101822A EP1956018A1 (de) 2007-02-06 2007-02-06 Verfahren zur Herstellung eines Benzimidazolderivats

Publications (1)

Publication Number Publication Date
CL2008000355A1 true CL2008000355A1 (es) 2008-06-20

Family

ID=38166801

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800355A CL2008000355A1 (es) 2007-02-06 2008-02-05 Procedimiento de preparacion de un compuesto derivado de 1-metil-2-fenilamino metil-1h-benzoimidazol-5-amida; compuesto intermediario hidrobromuro.

Country Status (34)

Country Link
US (2) US8119810B2 (es)
EP (2) EP1956018A1 (es)
JP (1) JP5247728B2 (es)
KR (1) KR20090116781A (es)
CN (1) CN101600709B (es)
AR (1) AR065196A1 (es)
AT (1) ATE476430T1 (es)
AU (1) AU2008212908B2 (es)
BR (1) BRPI0807197A2 (es)
CA (1) CA2675624C (es)
CL (1) CL2008000355A1 (es)
CY (1) CY1111045T1 (es)
DE (1) DE602008002057D1 (es)
DK (1) DK2118090T3 (es)
EA (1) EA015967B1 (es)
EC (1) ECSP099509A (es)
ES (1) ES2349905T3 (es)
HK (1) HK1136559A1 (es)
HR (1) HRP20100458T1 (es)
IL (1) IL199330A (es)
MA (1) MA31118B1 (es)
MX (1) MX2009006834A (es)
MY (1) MY148629A (es)
NZ (1) NZ579133A (es)
PE (1) PE20081737A1 (es)
PL (1) PL2118090T3 (es)
PT (1) PT2118090E (es)
SI (1) SI2118090T1 (es)
TN (1) TN2009000327A1 (es)
TW (1) TWI417291B (es)
UA (1) UA94988C2 (es)
UY (1) UY30888A1 (es)
WO (1) WO2008095928A1 (es)
ZA (1) ZA200906050B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
CZ305085B6 (cs) * 2008-03-14 2015-04-29 Zentiva, K.S. Způsob přípravy dabigatranu
EP2288335A1 (en) * 2008-03-28 2011-03-02 Boehringer Ingelheim International GmbH Process for preparing orally administered dabigatran formulations
EP2297132B1 (de) 2008-06-16 2015-02-25 Boehringer Ingelheim International GmbH Verfahren zur herstellung eines zwischenprodukts von dabigatran etexilate
TWI436994B (zh) * 2008-07-14 2014-05-11 Boehringer Ingelheim Int 製備含有達比加群（ｄａｂｉｇａｔｒａｎ）之藥物組合物的新穎方法
NZ592616A (en) 2008-11-11 2013-04-26 Boehringer Ingelheim Int Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
CN102050815B (zh) * 2009-11-06 2014-04-02 北京美倍他药物研究有限公司 作为前药的达比加群的酯衍生物
CN102050814B (zh) * 2009-11-06 2014-05-28 北京美倍他药物研究有限公司 达比加群的酯衍生物
US8399678B2 (en) 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
EP2937343A1 (en) 2010-07-09 2015-10-28 Esteve Química, S.A. Process of preparing a thrombin specific inhibitor
WO2012077136A2 (en) * 2010-12-06 2012-06-14 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and its salts
CN102838588B (zh) * 2011-06-24 2014-03-19 中国药科大学 一类可用于口服的凝血酶抑制剂、其制法以及医药用途
CN102633713B (zh) * 2012-03-22 2013-12-11 南京工业大学 达比加群酯中间体及其制备方法、以及制备达比加群酯的方法
EP2834224B1 (en) 2012-04-02 2018-06-06 MSN Laboratories Limited Process for the preparation of benzimidazole derivatives and salts thereof
CN102911160B (zh) * 2012-06-29 2014-10-22 上海奥博生物医药技术有限公司 一种制备和纯化达比加群酯中间体的方法
JP2015522596A (ja) * 2012-07-16 2015-08-06 インテルキム、ソシエダッド アノニマ ダビガトランエテキシラートの合成のための中間体を調製する方法及び該中間体の結晶形
US10077251B2 (en) 2012-10-29 2018-09-18 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of Dabigatran Etexilate and its intermediates
WO2014068587A2 (en) * 2012-10-29 2014-05-08 Biophore India Pharmaceuticals Pvt. Ltd. An improved process for the synthesis of dabigatran and its intermediates
CN102977077A (zh) * 2012-11-28 2013-03-20 浙江燎原药业有限公司 一种达比加群酯中间体的制备方法
CN103224469A (zh) * 2013-05-16 2013-07-31 上海应用技术学院 一种以含氟基团修饰的苯环为中心的达比加群酯类似物及其合成方法
CN103288744A (zh) * 2013-06-04 2013-09-11 上海应用技术学院 一种含氟基团修饰的达比加群酯类似物及其合成方法
CN104418839B (zh) * 2013-08-26 2019-02-01 深圳翰宇药业股份有限公司 达比加群酯的合成方法
CN103710406B (zh) * 2013-12-05 2017-08-11 蚌埠丰原医药科技发展有限公司 一种酶促反应制备达比加群酯主要中间体的方法
CN103772358A (zh) * 2014-01-07 2014-05-07 万特制药(海南)有限公司 一种制备达比加群酯的合成方法
CN104003977B (zh) * 2014-06-05 2016-04-13 雅本化学股份有限公司 N-(2-氯甲基-1-甲基-1h-苯并咪唑-5-酰基)-n-(吡啶-2-基) -3-氨基丙酸乙酯的制备方法
CN104045628B (zh) * 2014-06-13 2019-04-09 深圳翰宇药业股份有限公司 苯并咪唑衍生物的纯化方法
CN105315257A (zh) * 2014-06-24 2016-02-10 华仁药业股份有限公司 一种达比加群酯的合成及纯化方法
WO2016000230A1 (zh) 2014-07-03 2016-01-07 上海医药工业研究院 一种达比加群酯中间体的制备方法及中间体化合物
WO2016027077A1 (en) * 2014-08-18 2016-02-25 Cipla Limited Processes for the preparation of dabigatran etexilate and intermediates thereof
CN104744438A (zh) * 2014-12-17 2015-07-01 烟台东诚药业集团股份有限公司 一种用于合成制备达比加群酯苯并咪唑中间体的方法
WO2016132296A1 (en) * 2015-02-18 2016-08-25 Piramal Enterprises Limited A process for the preparation of an intermediate of dabigatran etexilate
CN105601615A (zh) * 2015-11-17 2016-05-25 烟台东诚药业集团股份有限公司 一种用于纯化公斤级达比加群酯游离碱的方法
CN105330645B (zh) * 2015-11-30 2020-06-02 常州市阳光药业有限公司 达比加群酯中间体的制备方法
CN106866626A (zh) * 2015-12-14 2017-06-20 天津药物研究院有限公司 一种达比加群酯中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
JPH02283860A (ja) * 1989-04-24 1990-11-21 Nissan Motor Co Ltd エンジンの点火時期制御装置
US5233944A (en) * 1989-08-08 1993-08-10 Fuji Jukogyo Kabushiki Kaisha Control apparatus for alcohol engine
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
PE121699A1 (es) * 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
US6414008B1 (en) * 1997-04-29 2002-07-02 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
GB0014006D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
DE10230012A1 (de) * 2002-07-04 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 5,6-Dihydro-4H-imidazo[4,5,1-ij]chinoline,ihre Herstellung und ihre Verwendung als Arzneimittel
DE10235639A1 (de) * 2002-08-02 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel
EP1609784A1 (de) * 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
US7314033B2 (en) * 2004-11-18 2008-01-01 Massachusetts Institute Of Technology Fuel management system for variable ethanol octane enhancement of gasoline engines
CN100509799C (zh) * 2005-12-16 2009-07-08 复旦大学 一种合成非手性，非肽类的抗凝血酶抑制剂的方法

Also Published As

Publication number Publication date
PE20081737A1 (es) 2009-06-20
AR065196A1 (es) 2009-05-20
EP1956018A1 (de) 2008-08-13
NZ579133A (en) 2010-12-24
MA31118B1 (fr) 2010-01-04
EP2118090A1 (en) 2009-11-18
PT2118090E (pt) 2010-08-31
CA2675624A1 (en) 2008-08-14
UY30888A1 (es) 2008-09-30
CN101600709A (zh) 2009-12-09
ECSP099509A (es) 2009-08-28
UA94988C2 (ru) 2011-06-25
DE602008002057D1 (de) 2010-09-16
CA2675624C (en) 2014-07-08
MY148629A (en) 2013-05-15
CN101600709B (zh) 2012-12-12
HK1136559A1 (en) 2010-07-02
DK2118090T3 (da) 2010-11-01
JP2010517979A (ja) 2010-05-27
BRPI0807197A2 (pt) 2014-06-03
AU2008212908B2 (en) 2013-06-20
CY1111045T1 (el) 2015-06-11
KR20090116781A (ko) 2009-11-11
TWI417291B (zh) 2013-12-01
EA015967B1 (ru) 2012-01-30
HRP20100458T1 (hr) 2010-09-30
EA200901039A1 (ru) 2010-02-26
US8119810B2 (en) 2012-02-21
TW200838860A (en) 2008-10-01
US20100099882A1 (en) 2010-04-22
IL199330A (en) 2013-03-24
ZA200906050B (en) 2010-05-26
WO2008095928A1 (en) 2008-08-14
EP2118090B1 (en) 2010-08-04
AU2008212908A1 (en) 2008-08-14
US20120116089A1 (en) 2012-05-10
PL2118090T3 (pl) 2011-01-31
US8455650B2 (en) 2013-06-04
TN2009000327A1 (fr) 2010-12-31
MX2009006834A (es) 2009-08-13
JP5247728B2 (ja) 2013-07-24
ES2349905T3 (es) 2011-01-12
ATE476430T1 (de) 2010-08-15
SI2118090T1 (sl) 2010-11-30

Similar Documents

Publication Publication Date Title
CL2008000355A1 (es) Procedimiento de preparacion de un compuesto derivado de 1-metil-2-fenilamino metil-1h-benzoimidazol-5-amida; compuesto intermediario hidrobromuro.
CL2008000322A1 (es) Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios.
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
CL2007001040A1 (es) Proceso para la preparacion de antagonista de la sustancia p derivado de acil-amino-alquilen-amida.
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2021486T4 (da) System til fremstilling af bioorganiske forbindelser
DK2149545T3 (da) Fremgangsmåde til fremstilling af en benzaldehydforbindelse
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
CL2007002268A1 (es) Procedimiento de preparacion de compuestos derivados de ciclopropilamina opticamente activo; compuesto intermediario derivado de 2-aril ciclopropancarboxamida opticamente activo.
BRPI0815717A2 (pt) Compostos de imidazopirazina.
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
BRPI0811189A2 (pt) Ferramenta de nivelação composta.
DK2094676T3 (da) Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
CL2007003158A1 (es) Procedimiento de preparacion de compuestos derivados de quinazolina o sus sales farmaceuticamente aceptables; compuestos intermediarios; procedimiento de preparacion.
BRPI1007017A2 (pt) uso de um composto.
FI20065089A (fi) Menetelmä yhdistelmäsuolen valmistamiseksi
FI20055665A0 (fi) Prosessi haarautuneen hiilivetykomponentin valmistamiseksi
DK1843977T3 (da) Fremgangsmåde til fremstilling af cæsiumhydroxidopløsninger
BRPI1009816A2 (pt) "método para preparar um composto."
DK2241546T3 (da) Fremgangsmåde til fremstilling af en benzaldehydforbindelse
BRPI0817010A2 (pt) Processo de preparação de um composto p-hidroximandélico eventualmente substituído e derivado e de um aldeído 4-hidroxiaromático.
DK2229062T3 (da) Fremgangsmåde til fremstillingen af et hydrolysat
DK1866297T3 (da) Fremgangsmåde til fremstilling af en aminomethyl-thiazolforbindelse
BRPI0921210A2 (pt) processos para a preparação de compostos de arilaminas
DK2266990T3 (da) 3-PHENYLPYRAZOLO(5,1-b)THIAZOLFORBINDELSE